Shanghai's leading general hospital and a world centre for liver cancer surgery and research, home of the Liver Cancer Institute.
Zhongshan Hospital, founded in 1937, houses Fudan University's Liver Cancer Institute, which under Zhao-You Tang pioneered subclinical hepatocellular carcinoma detection with alpha-fetoprotein screening and small-HCC resection, and under Jia Fan and Jian Zhou continues to lead in liver transplantation for HCC, downstaging and conversion therapy, and circulating tumour cell research. The hospital is also strong in colorectal liver metastasis surgery, endoscopic resection of early gastrointestinal cancers and thoracic surgery, and its investigators contributed to the Chinese HCC immunotherapy trials. It is a national clinical research centre for interventional medicine.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-17.
Matched to Fudan University, including child institutions. 2,872 works · 31,534 citations · 76% open access · 8% clinical trials · 1% reviews.
Shares Thermal ablation (RFA, microwave, cryo), Robotic & minimally invasive surgery, Hepatocellular carcinoma, Colorectal cancer.
Shares Genomic and transcriptomic landscape of triple-negative breast cancers: subtypes and treatment strategies, Fudan University Shanghai Cancer Center.
Shares Thermal ablation (RFA, microwave, cryo), Robotic & minimally invasive surgery, Hepatocellular carcinoma.
Shares Fudan University Shanghai Cancer Center, Gastric & gastro-oesophageal junction cancer, Colorectal cancer.
Shares Genomic and transcriptomic landscape of triple-negative breast cancers: subtypes and treatment strategies, Fudan University Shanghai Cancer Center.
Shares Glypican-3, Hepatocellular carcinoma.
Shares Robotic & minimally invasive surgery, Hepatocellular carcinoma, Gastric & gastro-oesophageal junction cancer, Colorectal cancer.
Shares Robotic & minimally invasive surgery, Hepatocellular carcinoma, Colorectal cancer.